PVH
39
-5
CL
54
-4
NOC
47
2
IVZ
69
7
EXC
50
-3
LYB
11
-2
LRCX
56
-8
ADBE
46
-4
EQT
57
-7
FTI
64
-15
EMC
80
20
WM
50
-4
VRTX
47
-6
AXP
66
-4
ADSK
62
-4
TXN
53
-15
EOG
54
9
SLB
46
-2
REGN
50
-3
ADT
41
-7
PVH
39
-5
CL
54
-4
NOC
47
2
IVZ
69
7
EXC
50
-3
LYB
11
-2
LRCX
56
-8
ADBE
46
-4
EQT
57
-7
FTI
64
-15
EMC
80
20
WM
50
-4
VRTX
47
-6
AXP
66
-4
ADSK
62
-4
TXN
53
-15
EOG
54
9
SLB
46
-2
REGN
50
-3
ADT
41
-7
Financhill
Back

Apellis Pharmaceuticals, Inc. Vs. Structure Therapeutics, Inc. Industry Stock Comparison

Buy
54

APLS
Apellis Pharmaceuticals, Inc.

Last Price:
$23.80
Seasonality Move:
12.69%
Buy
67

GPCR
Structure Therapeutics, Inc.

Last Price:
$69.99
Seasonality Move:
-31.39%
Buy
54
Apellis Pharmaceuticals, Inc. (APLS) is a Buy

Is Apellis Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals, Inc. [APLS] share price is $23.79. The Score for APLS is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
67
Structure Therapeutics, Inc. (GPCR) is a Buy

Is Structure Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Structure Therapeutics, Inc. [GPCR] share price is $69.98. The Score for GPCR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

APLS Stock Price Chart

What is Apellis Pharmaceuticals, Inc.'s stock price today?

  • The Apellis Pharmaceuticals, Inc. share price today is $23.79
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing selling pressure, which indicates risk of future bearish movement.

GPCR Stock Price Chart

What is Structure Therapeutics, Inc.'s stock price today?

  • The Structure Therapeutics, Inc. share price today is $69.98
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing slight buying pressure.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.01 Buy
Relative Strength Index (14 RSI): 62.23 Buy
Chaikin Money Flow: -1539673 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.35 - 21.77) Buy
Bollinger Bands (100): (20.52 - 26.86) Buy

GPCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.48 Buy
Relative Strength Index (14 RSI): 86.01 Buy
Chaikin Money Flow: 124529 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.63 - 42.89) Buy
Bollinger Bands (100): (18.11 - 33.75) Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.95 Buy
20-day SMA: 20.69 Buy
50-day SMA: 22.96 Buy
200-day SMA: 21.97 Buy
8-day EMA: 22.17 Buy
20-day EMA: 21.64 Buy
50-day EMA: 22.39 Buy
200-day EMA: 24.23 Sell

GPCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.22 Buy
20-day SMA: 36.44 Buy
50-day SMA: 32.1 Buy
200-day SMA: 23.71 Buy
8-day EMA: 41.78 Buy
20-day EMA: 37.11 Buy
50-day EMA: 32.59 Buy
200-day EMA: 27.3 Buy

Apellis Pharmaceuticals, Inc. Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.00 per share, and a decrease next year of $1.42 per share.

Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.49 per share, and a decrease next year of $0.15 per share.

Apellis Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Structure Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):